Cargando…

Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area

BACKGROUND: Association of thyroid dysfunction (TD) with interferon treatment of HCV is well known to clinicians. However, a few studies have highlighted the role of hepatitis C virus per se in the development of TD. The aim of this study was to know the prevalence of TD in non-interferon treated HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batool, Nayab, Elahi, Shan, Saleem, Nazish, Ashraf, Abrar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468572/ https://www.ncbi.nlm.nih.gov/pubmed/28638825 http://dx.doi.org/10.1155/2017/2390812

Ejemplares similares

Prevalence of Vitamin D Deficiency and Its Association with Insulin Resistance in Obese Women with Normal Fasting Glucose
por: Saleem, Nazish, et al.
Publicado: (2021)

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2015)

Reluctance in use of iodized salt for elimination of iodine deficiency
por: Elahi, Shan, et al.
Publicado: (2015)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors
por: Yan, Zehui, et al.
Publicado: (2012)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Prevalence of Thyroid Dysfunction in Patients With Hepatitis C
por: Nazary, Kefayatullah, et al.
Publicado: (2021)

Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon
por: Luo, Wenfan, et al.
Publicado: (2021)

A Longitudinal Study of Changes in Thyroid Related Hormones among Pregnant Women Residing in an Iodine Deficient Urban Area
por: Elahi, Shan, et al.
Publicado: (2013)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
por: Liu, Yisi, et al.
Publicado: (2023)

Seroprevalence of Hepatitis B and C among Children in Endemic Areas of Turkey
por: Kangin, Murat, et al.
Publicado: (2010)

Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
por: Krupińska, Janina, et al.
Publicado: (2012)

Epidemiology of Hepatitis C Virus Infection in Highly Endemic HBV Areas in China
por: Li, Duan, et al.
Publicado: (2013)

Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2013)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
por: Huang, Shiu‐Feng, et al.
Publicado: (2018)

B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
por: Kajiyama, Yusuke, et al.
Publicado: (2012)

Changing Pattern of Hepatitis A Virus Epidemiology in an Area of High Endemicity
por: Campagna, Marcello, et al.
Publicado: (2012)

Southern Tunisia: A still high endemicity area for hepatitis A
por: Neffatti, Houcine, et al.
Publicado: (2017)

Evaluation of health status in patients with hepatitis c treated with and without interferon
por: Ragusa, R., et al.
Publicado: (2018)

Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
por: Goyal, Gitanjali, et al.
Publicado: (2016)

Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2012)

Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
por: Kashif, Muhammad, et al.
Publicado: (2015)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

Thyroid dysfunction and hepatic steatosis in overweight children and adolescents
por: Kaltenbach, T. E.‐M., et al.
Publicado: (2016)

Risk of hepatitis B when migrating from low to high endemic areas
por: Krarup, Henrik Bygum, et al.
Publicado: (2020)

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
por: Trien, Remi, et al.
Publicado: (2014)

Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report
por: Jang, Hyunil, et al.
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura in a Patient with Interferon Treated Hepatitis C Successfully Treated with Rituximab
por: Poddar, Nishant, et al.
Publicado: (2013)

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
por: Chang, Yu-Kang, et al.
Publicado: (2019)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
por: Shim, Chang Woo, et al.
Publicado: (2017)

Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus
por: Lee, Hae Lim, et al.
Publicado: (2021)

Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area
por: Shin, Jongbeom, et al.
Publicado: (2021)

‘Double-hit’ pegylated interferon-alpha successfully treats Hepatitis B and Hepatitis D co-infection
por: Bhuva, Meha, et al.
Publicado: (2020)

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
por: Yeh, Chau-Ting, et al.
Publicado: (2009)

Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area
por: Ungtrakul, Teerapat, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l027oorarfh75l0f5jmdqrrnsr